aTyr Pharma
ATYR
#9507
Rank
ยฃ57.25 M
Marketcap
ยฃ0.58
Share price
-3.92%
Change (1 day)
-77.30%
Change (1 year)

Revenue for aTyr Pharma (ATYR)

Revenue in 2025 (TTM): ยฃ0.14 Million

According to aTyr Pharma's latest financial reports the company's current revenue (TTM ) is ยฃ0.14 Million. In 2024 the company made a revenue of ยฃ0.18 Million a decrease over the revenue in the year 2023 that were of ยฃ0.27 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for aTyr Pharma from 2014 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ0.14 M-24.53%
2024 ยฃ0.18 M-32.42%
2023 ยฃ0.27 M-96.77%
2022 ยฃ8.58 M
2021 N/A-100%
2020 ยฃ7.67 M2283.4%
2019 ยฃ0.32 M
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Veracyte
VCYT
ยฃ0.36 B 260,500.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
ยฃ8.73 B 6,170,057.89%๐Ÿ‡บ๐Ÿ‡ธ USA